Cargando…

Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure

BACKGROUND: Results of recent clinical trials have shown that in heart failure (HF) heart rate (HR) values > 70 beats/minute are associated with an increased cardiovascular risk. No information is available on whether the sympathetic nervous system is differently activated in HF patients displayi...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassi, Guido, Seravalle, Gino, Vanoli, Jennifer, Facchetti, Rita, Spaziani, Domenico, Mancia, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849312/
https://www.ncbi.nlm.nih.gov/pubmed/35552503
http://dx.doi.org/10.1007/s00392-022-02028-9
_version_ 1784871930091798528
author Grassi, Guido
Seravalle, Gino
Vanoli, Jennifer
Facchetti, Rita
Spaziani, Domenico
Mancia, Giuseppe
author_facet Grassi, Guido
Seravalle, Gino
Vanoli, Jennifer
Facchetti, Rita
Spaziani, Domenico
Mancia, Giuseppe
author_sort Grassi, Guido
collection PubMed
description BACKGROUND: Results of recent clinical trials have shown that in heart failure (HF) heart rate (HR) values > 70 beats/minute are associated with an increased cardiovascular risk. No information is available on whether the sympathetic nervous system is differently activated in HF patients displaying resting HR values above or below this cutoff. METHODS: In 103 HF patients aged 62.7 ± 0.9 (mean ± SEM) years and in 62 heathy controls of similar age we evaluated muscle sympathetic nerve traffic (MSNA, microneurography) and venous plasma norepinephrine (NE, HPLC assay), subdividing the subjects in different groups according to their resting clinic and 24-h HR values. RESULTS: In HF progressively greater values of clinic or 24-h HR were associated with a progressive increase in both MSNA and NE. HR cutoff values adopted in large scale clinical trials for determining cardiovascular risk, i.e., 70 beats/minute, were associated with MSNA values significantly greater than the ones detected in patients with lower HR, this being the case also for NE. In HF both MSNA and NE were significantly related to clinic (r = 0.92, P < 0.0001 and r = 0.81, P < 0.0001, respectively) and 24-h (r = 0.91, P < 0.0001 and r = 0.79, P < 0.0001, respectively) HR. The behavior of sympathetic markers described in HF was specific for this clinical condition, being not observed in healthy controls. CONCLUSIONS: Both clinic and 24-h HR values greater than 70 beats/minute are associated with an increased sympathetic activation, which parallels for magnitude the HR elevations. These findings support the relevance of using in the therapeutic approach to HF drugs exerting sympathomoderating properties. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9849312
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98493122023-01-20 Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure Grassi, Guido Seravalle, Gino Vanoli, Jennifer Facchetti, Rita Spaziani, Domenico Mancia, Giuseppe Clin Res Cardiol Original Paper BACKGROUND: Results of recent clinical trials have shown that in heart failure (HF) heart rate (HR) values > 70 beats/minute are associated with an increased cardiovascular risk. No information is available on whether the sympathetic nervous system is differently activated in HF patients displaying resting HR values above or below this cutoff. METHODS: In 103 HF patients aged 62.7 ± 0.9 (mean ± SEM) years and in 62 heathy controls of similar age we evaluated muscle sympathetic nerve traffic (MSNA, microneurography) and venous plasma norepinephrine (NE, HPLC assay), subdividing the subjects in different groups according to their resting clinic and 24-h HR values. RESULTS: In HF progressively greater values of clinic or 24-h HR were associated with a progressive increase in both MSNA and NE. HR cutoff values adopted in large scale clinical trials for determining cardiovascular risk, i.e., 70 beats/minute, were associated with MSNA values significantly greater than the ones detected in patients with lower HR, this being the case also for NE. In HF both MSNA and NE were significantly related to clinic (r = 0.92, P < 0.0001 and r = 0.81, P < 0.0001, respectively) and 24-h (r = 0.91, P < 0.0001 and r = 0.79, P < 0.0001, respectively) HR. The behavior of sympathetic markers described in HF was specific for this clinical condition, being not observed in healthy controls. CONCLUSIONS: Both clinic and 24-h HR values greater than 70 beats/minute are associated with an increased sympathetic activation, which parallels for magnitude the HR elevations. These findings support the relevance of using in the therapeutic approach to HF drugs exerting sympathomoderating properties. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-05-12 2023 /pmc/articles/PMC9849312/ /pubmed/35552503 http://dx.doi.org/10.1007/s00392-022-02028-9 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Grassi, Guido
Seravalle, Gino
Vanoli, Jennifer
Facchetti, Rita
Spaziani, Domenico
Mancia, Giuseppe
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
title Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
title_full Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
title_fullStr Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
title_full_unstemmed Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
title_short Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
title_sort relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849312/
https://www.ncbi.nlm.nih.gov/pubmed/35552503
http://dx.doi.org/10.1007/s00392-022-02028-9
work_keys_str_mv AT grassiguido relationshipsbetweensympatheticmarkersandheartratethresholdsforcardiovascularriskinchronicheartfailure
AT seravallegino relationshipsbetweensympatheticmarkersandheartratethresholdsforcardiovascularriskinchronicheartfailure
AT vanolijennifer relationshipsbetweensympatheticmarkersandheartratethresholdsforcardiovascularriskinchronicheartfailure
AT facchettirita relationshipsbetweensympatheticmarkersandheartratethresholdsforcardiovascularriskinchronicheartfailure
AT spazianidomenico relationshipsbetweensympatheticmarkersandheartratethresholdsforcardiovascularriskinchronicheartfailure
AT manciagiuseppe relationshipsbetweensympatheticmarkersandheartratethresholdsforcardiovascularriskinchronicheartfailure